Henry Moore

1.2k total citations
33 papers, 659 citations indexed

About

Henry Moore is a scholar working on Neurology, Epidemiology and Genetics. According to data from OpenAlex, Henry Moore has authored 33 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 5 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Henry Moore's work include Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Henry Moore is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Henry Moore collaborates with scholars based in United States, Argentina and Spain. Henry Moore's co-authors include Carlos Singer, Oscar S. Gershanik, Glenn T. Stebbins, Mayela Rodríguez‐Violante, Mónica Kurtis, Anabel Chade, Juan Carlos Martínez‐Castrillo, Tomoko Arakaki, Alberto Bergareche‐Yarza and Christopher G. Goetz and has published in prestigious journals such as Blood, Neurology and Annals of Neurology.

In The Last Decade

Henry Moore

26 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Moore United States 13 454 114 105 71 69 33 659
Corneliu Luca United States 14 370 0.8× 121 1.1× 60 0.6× 121 1.7× 64 0.9× 45 623
Martijn Broen Netherlands 11 649 1.4× 91 0.8× 116 1.1× 40 0.6× 48 0.7× 17 825
V. Campos Arillo Spain 11 481 1.1× 154 1.4× 84 0.8× 57 0.8× 58 0.8× 15 680
Meredith Spindler United States 15 488 1.1× 161 1.4× 106 1.0× 37 0.5× 171 2.5× 38 772
Guilherme Riccioppo Rodrigues Brazil 14 215 0.5× 111 1.0× 69 0.7× 37 0.5× 77 1.1× 29 487
Pettarusp M. Wadia India 9 366 0.8× 158 1.4× 105 1.0× 34 0.5× 38 0.6× 15 528
Graeme J.A. Macphee United Kingdom 12 512 1.1× 238 2.1× 125 1.2× 54 0.8× 47 0.7× 18 934
Greg Kearns United States 6 257 0.6× 125 1.1× 48 0.5× 28 0.4× 24 0.3× 6 389
Samantha K. Holden United States 15 525 1.2× 270 2.4× 195 1.9× 22 0.3× 93 1.3× 44 806
Verónica Puertas‐Martín Spain 19 355 0.8× 261 2.3× 134 1.3× 19 0.3× 151 2.2× 40 869

Countries citing papers authored by Henry Moore

Since Specialization
Citations

This map shows the geographic impact of Henry Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Moore more than expected).

Fields of papers citing papers by Henry Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Moore. The network helps show where Henry Moore may publish in the future.

Co-authorship network of co-authors of Henry Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Moore. A scholar is included among the top collaborators of Henry Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Moore. Henry Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCausland, Joshua W., S. Solís, Michael Escobar, et al.. (2025). The polyadenylase PAPI is required for virulence plasmid maintenance in pathogenic bacteria. PLoS Pathogens. 21(5). e1012655–e1012655. 1 indexed citations
2.
Shih, Ludy C., Michael Stevenson, Steven Bellows, et al.. (2024). Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living. Tremor and Other Hyperkinetic Movements. 14. 26–26. 1 indexed citations
3.
Margolesky, Jason, Corneliu Luca, Henry Moore, et al.. (2023). Blepharoclonus in Parkinsonism. Neurology Clinical Practice. 14(1). e200240–e200240. 1 indexed citations
4.
Luca, Corneliu, et al.. (2023). Deep Brain Stimulation for an Unusual Presentation of Myoclonus Dystonia Associated with Russell-Silver Syndrome. Tremor and Other Hyperkinetic Movements. 13(1). 40–40. 1 indexed citations
6.
Margolesky, Jason, Corneliu Luca, Carlos Singer, et al.. (2021). Do Benzodiazepines Impair Motor and Nonmotor Symptoms in a Sample of Parkinson’s Disease Patients?. Cureus. 13(2). e13220–e13220. 4 indexed citations
7.
Luca, Daniel G. Di, Jason Margolesky, Joacir Graciolli Cordeiro, et al.. (2020). Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease. Parkinsonism & Related Disorders. 77. 13–17. 18 indexed citations
8.
Margolesky, Jason, et al.. (2020). Blepharoclonus in Parkinson’s Disease: a prevalent and meaningful finding? (2174). Neurology. 94(15_supplement). 2 indexed citations
9.
10.
Margolesky, Jason, Corneliu Luca, Carlos Singer, et al.. (2019). Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in Parkinson's disease patients?. Parkinsonism & Related Disorders. 63. 131–136. 6 indexed citations
11.
Margolesky, Jason, Chuanhui Dong, Tatjana Rundek, et al.. (2019). Tandem gait abnormality in Parkinson disease: Prevalence and implication as a predictor of fall risk. Parkinsonism & Related Disorders. 63. 83–87. 9 indexed citations
12.
Luca, Daniel G. Di, Iahn Cajigas, Jason Margolesky, et al.. (2019). Gender Disparities in Deep Brain Stimulation for Parkinson’s Disease. Neuromodulation Technology at the Neural Interface. 22(4). 484–488. 36 indexed citations
13.
Moore, Henry, et al.. (2019). Management of Motor Features in Advanced Parkinson Disease. Clinics in Geriatric Medicine. 36(1). 43–52. 5 indexed citations
14.
Barbouth, Deborah, et al.. (2019). Uniparental Disomy Causing Myoclonus Dystonia Associated with Russell Silver Syndrome. Movement Disorders Clinical Practice. 6(5). 409–410. 1 indexed citations
16.
Singer, Carlos, et al.. (2018). Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence. Therapeutics and Clinical Risk Management. Volume 14. 1737–1745. 46 indexed citations
17.
Shafazand, Shirin, Douglas M. Wallace, Kristopher L. Arheart, et al.. (2017). Insomnia, Sleep Quality, and Quality of Life in Mild to Moderate Parkinson’s Disease. Annals of the American Thoracic Society. 14(3). 412–419. 34 indexed citations
18.
Moore, Henry, et al.. (2014). A Case of Klinefelter Syndrome Associated with Parkinsonism (P5.255). Neurology. 82(10_supplement).
19.
Martínez‐Martín, Pablo, Carmen Rodríguez‐Blázquez, Maria João Forjaz, et al.. (2014). Relationship between the MDS‐UPDRS domains and the health‐related quality of life of Parkinson's disease patients. European Journal of Neurology. 21(3). 519–524. 40 indexed citations
20.
Rodríguez‐Blázquez, Carmen, José Manuel Rojo-Abuín, Mario Álvarez, et al.. (2013). The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism & Related Disorders. 19(10). 889–893. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026